A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at ...
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Diabetes, Cancer), Dosage Form, ...
Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...
For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is ...
Background and goal: Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have asthma ...
1d
Health on MSNWhat's the Difference Between Asthma and Chronic Obstructive Pulmonary Disease (COPD)?Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...
4d
Pharmaceutical Technology on MSNEMA to review GSK’s Nucala for COPD treatment expansionThe European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...
Chronic obstructive pulmonary disease (COPD) is a challenge, but it isn’t one that needs to get in the way of a regular life. With a good diet, the right care, and some patience, you can live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results